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Stellera chamaejasme L. has been used as a traditional Chinese medicine for the treatment of
scabies, tinea, stubborn skin ulcers, chronic tracheitis, cancer and tuberculosis. A sensitive and
selective ultra‐high liquid chromatography–tandem mass spectrometry (UPLC‐MS/MS) method
was developed and validated for the simultaneous determination of five flavonoids (stelleranol,
chamaechromone, neochamaejasmin A, chamaejasmine and isochamaejasmin) of S. chamaejasme
L. in rat plasma. Chromatographic separation was accomplished on an Agilent Poroshell 120 EC‐
C18 column (2.1 × 100mm, 2.7 μm) with gradient elution at a flow rate of 0.4mL/min and the
total analysis time was 7min. The analytes were detected using multiple reaction monitoring
in positive ionization mode. The samples were prepared by liquid–liquid extraction with ethyl
acetate. The UPLC‐MS/MS method was validated for specificity, linearity, sensitivity, accuracy
and precision, recovery, matrix effect and stability. The validated method exhibited good
linearity (r ≥ 0.9956), and the lower limits of quantification ranged from 0.51 to 0.64 ng/mL
for five flavonoids. The intra‐ and inter‐day precision were both <10.2%, and the accuracy
ranged from −11.79 to 9.21%. This method was successfully applied to a pharmacokinetic study
of five flavonoids in rats after oral administration of ethyl acetate extract of S. chamaejasme L.
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Stellera chamaejasme L. (Thymelaeaceae), a perennial weed, is
distributed widely across the grasslands of Russia, Mongolia and
China (Shirai et al., 2015; Yan et al., 2014; Yan, Zeng, Jin, & Qin,
2015). Its roots are commonly known as ‘Ruixianglang du’ in
Chinese, and have been used in China as a traditional Chinese
medicine for the treatment of scabies, tinea, stubborn skin ulcers,
chronic tracheitis, cancer and tuberculosis (Xu, Qin, Li, & Xu, 2001;
Zhang et al., 2013; Pan et al., 2015). Previous phytochemical studies
of S. chamaejasme L. have shown that it contains various kinds ofaejasme L.; LLE, liquid–liquid
ork.
wileyonlinelibrary.com/jochemical components, including diterpene, lignans, coumarins,
phenylpropanoid, flavonoids and volatile oil (Li, Shen, Bao, Chen, &
Li, 2014; Yan et al., 2014; Zhang et al., 2015). Modern studies have
suggested that flavonoids from S. chamaejasme L. are the main com-
ponents that mostly contribute to the pharmacological efficacy (Liu
et al., 2012; Liu & Zhu, 2012; Liu, Han, et al., 2014; Liu, Yang,
et al., 2014), such as anti‐cancer activity (Liu et al., 2012; Li, Zhang,
Pang, ZhengChen, & Gan, 2014), anti‐fatty liver (Wang, Li, Han,
Wang, & Li, 2015) and anti‐HIV (Asada et al., 2013).
In our earlier research, some flavonoids have been isolated and
identified from ethyl acetate extract of S. chamaejasme L. (ESL), and
five flavonoids – stelleranol, chamaechromone, neochamaejasmin A,
chamaejasmine and isochamaejasmin – have been detected in the rat
plasma and tissues after oral administration of ESL. All of them are
active compounds of the herbal preparation with pharmacologicalCopyright © 2018 John Wiley & Sons, Ltd.urnal/bmc 1 of 8
2 of 8 LI ET AL.effects. Stelleranol was found to have potential antiviral activity
against respiratory syncytial virus (Huang et al., 2010). Yang and Chen
(2008) demonstrated that chamaechromone has and anti‐viral effect on
hepatitis B virus. Neochamaejasmin A, meanwhile, was reported to
induce apoptosis in human prostate cancer cells. According to previous
research, chamaejasmine has a profound anti‐proliferative effect on
human osteosarcoma, breast cancer, lung adenocarcinoma A549 and
HEp‐2 larynx carcinoma cells (Yu et al., 2011; Zhang, Yu, Dong, Cai, &
Bai, 2013; Yang,Wang, & Ren, 2015). In addition, Zhang et al. discovered
that isochamaejasmin could induce apoptosis in leukemia cells through
inhibiting the Bcl‐2 family proteins (Zhang, Shan, Li, Li, & Zhang, 2015).
However, there is almost no report on pharmacokinetic studies of
simultaneous determination of those five flavonoids in rat plasma after
administration of ESL. In this study, a rather selective and sensitive
UPLC‐MS/MS method was developed and validated for simulta-
neously determining stelleranol, chamaechromone, neochamaejasmin
A, chamaejasmine and isochamaejasmin in rat plasma. The results of
this study would be helpful for improving clinical application and fur-
ther pharmacological studies of S. chamaejasme L.2 | EXPERIMENTAL
2.1 | Chemicals and reagents
Stelleranol, chamaechromone, neochamaejasmin A, chamaejasmine,
isochamaejasmin and quercetin were purchased from Nature Standard(Shanghai, China) (purity >98.0%). Quercetin was used an an internal
standard (IS). The chemical structures of these compounds are shown
in Figure 1. Acetonitrile, ethanol, ethyl acetate, petroleum ether and
formic acid were of HPLC grade, and supplied by Merck (Germany).
Ultra‐pure water was prepared using a PW water system (Heal Force,
Hong Kong).2.2 | Instruments and UPLC‐MS/MS conditions
The UPLC system was an Agilent Technology 1290 series equipped
with an online degasser, a G7120A binary pump, a G7167B
autosampler and a G7116B thermostatic column. Chromatographic
separation was achieved on an Agilent Poroshell 120 EC‐C18 column
(2.1 × 100mm, 2.7 μm) at 25°C. The mobile phase consisted of meth-
anol–water containing 0.1% formic acid with a gradient elution starting
at 45% methanol and progressing linearly to 75% methanol over 6min
then returning to 45% methanol. The flow rate was 0.4mL/min and
the total analysis time was 6min. A 5 μL aliquot of sample solution
was injected, with a needle wash process that was used to wash the
outer wall of sample needle after each injection.
The mass spectrometric detection was performed on a 6470 triple
quad mass spectrometer (Agilent, USA) in positive ionization mode. An
Agilent Mass Hunter workstation (Agilent, USA) was used to control
the equipment and for data acquisition and analysis. The quantification
was obtained using multiple reaction monitoring of the precursor–
product ion transition at m/z 559.2 → 153.0 for stelleranol, 543.3 →FIGURE 1 The chemical structures of five
flavonoids and the internal standard
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543.1→ 152.9 forchamaejasmin, 543.2→ 153.0 for isochamaejasmin
and m/z 303.1 → 153.1 for quercetin (IS). Other parameters of the
mass spectrometer were set as follows: a drying gas flow of 5 L/min;
a drying gas temperature of 200°C; a nebulizer pressure of 45 psig;
and a capillary voltage of 4000 V.
2.3 | Preparation of ESL
For preparation of the extract, the dried powder of S. chamaejasme L.
(1 kg) was extracted under reflux with 4000mL ethanol–water
(80:20, v/v) twice, 2 h each time, and then filtered. Ethanol was
recovered under reduced pressure, and then extracted with petroleum
ether and ethyl acetate successively several times. Ethyl acetate
extract was obtained by vacuum freeze drying. The extract was
reconstituted in 15% ethanol–water to get a concentration equivalent
to 0.25 g/mL of ESL.
2.4 | Preparation of calibration standards and quality
control samples
The stock solutions of stelleranol, chamaechromone, neochamaejasmin
A, chamaejasmine, isochamaejasmin and the IS (quercetin) were indi-
vidually prepared in methanol. The stock solutions of the standards
were further diluted in methanol to produce combined standard work-
ing solutions at a series of concentrations. The IS solution (94.2 ng/mL)
was obtained by diluting the stock solution in methanol. The samples
for standard calibration curves were prepared by spiking the appropri-
ate amount of the standard solutions in 100 μL blank plasma to yield
calibration concentrations of 1280, 640.0, 320.0, 128.0, 64.00,
32.00, 12.80, 6.400, 1.280 and 0.6400 ng/mL for stelleranol; 1060,
530.0, 265.0, 106.0, 53.00, 26.50, 10.60, 5.300, 1.060 and
0.5300 ng/mL for chamaechromone; 1055, 527.5, 263.8, 105.5,
52.75, 26.38, 10.55, 5.275, 1.055 and 0.5275 ng/mL for
neochamaejasmin A; 1160, 580.0, 290.0, 116.0, 58.00, 29.00, 11.60,
5.800, 1.160 and 0.5800 for chamaejasmine; 1020, 510.0, 255.0,
102.0, 51.00, 25.50, 10.20, 5.100, 1.020 and 0.5100 ng/mL for
isochamaejasmin, respectively. Quality control (QC) samples include
low QC (LQC), middle QC (MQC) and high QC (HQC). The QC samples
were prepared at 1.280, 128.0 and 1280 ng/mL for stelleranol; 1.060,
106.0 and 1060 ng/mL for chamaechromone; 1.055, 105.5 and
1055 ng/mL for neochamaejasmin A; 1.160, 116.0 and 1160 ng/mL
for chamaejasmine; and 1.020, 102.0 and 1020 for isochamaejasmin.
Calibration work solutions and QC samples were stored at 4°C until
UPLC‐MS/MS analysis.
2.5 | Preparation of plasma samples
The plasma samples were frozen and stored at −40°C in the refrigera-
tor and were thawed at room temperature by vortex before use. The
liquid–liquid extraction (LLE) method was applied to extract the
analytes and IS from rat plasma. After 100 μL of plasma sample was
transferred into a 1.5mL centrifuge tube, 20 μL of IS working solution
(94.2 ng/mL) was added. The mixture was vortex‐mixed for 2min and
extracted with 900 μL of ethyl acetate by vortex‐mixing for 5min.
Then the sample was centrifuged at 13,800 g for 10min. Thesupernatant was transferred into another test tube and evaporated
to dryness with nitrogen gas at room temperature. The residue was
reconstituted in 50 μL of the initial mobile phase by vortex‐mixing
for 2min and centrifuged at 13,800 g for 10min. Finally, 5 μL superna-
tant was injected for UPLC‐MS/MS analysis.2.6 | Method validation
The validation method for stelleranol, chamaechromone, neochama-
ejasmin A, chamaejasmine and isochamaejasminin rat plasma was done
following the guidelines of the US Food and Drug Administration
(2013). The validation parameters included specificity, linearity, sensi-
tivity, accuracy and precision, recovery, matrix effect and stability.2.6.1 | Specificity
Specificity is the ability of an analytical method to differentiate and
quantify the analytes in the presence of other components in the sam-
ple. In this paper, the specificity was ascertained by comparatively ana-
lyzing blank plasma samples from six individual rats, corresponding
blank plasma spiked with the five analytes and IS and the plasma sam-
ples from the rats after oral administration of ESL.2.6.2 | Linearity, lower limits of quantification and lower
limit of detection
Calibration curves were prepared by assaying standard plasma samples
at 10 concentration levels. The linearity of each calibration curve was
determined by plotting the peak area ratio (y) of analytes to IS vs the
nominal concentration (x) of analytes with a weighted (1/x2) least
square linear regression. Six replicate samples were used for evalua-
tion. The LLOD and LLOQ were determined as the concentration of
the analytes with a signal‐to‐noise ratio at 3 and 5, respectively.2.6.3 | Accuracy and precision
Three validation batches, each containing six replicates of LLOQ and
QC samples at low, medium and high concentration levels, were
assayed to assess the precision and accuracy of the method on three
different days. The intra‐ and inter‐day precisions were defined as
the relative standard deviation with criteria of <15% for QC samples
and 20% for LLOQ; the accuracy was assessed by comparing the
measured concentration with its nominal value with a criterion of
within ±15% for QC samples and 20% for LLOQ.2.6.4 | Recovery and matrix effect
The recovery of analytes and IS was determined by comparing the
responses of the analytes from QC samples with the responses of
analytes spiked in post‐extracted blank rat plasma at equivalent
concentrations. The matrix effects were evaluated quantitatively
for six different lots of black rat plasma and evaluated at three QC
concentrations in triplicate to know the individual distinctions of
matrix effect. The matrix effects were calculated by determining
the peak area ratios of the analytes in post‐extracted spiked samples
with those of pure standard solutions containing analytes at the
equivalent concentration.
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The stability of the five flavonoids in samples including room‐
temperature stability (storage for 6 h at ambient temperature), long‐
term stability (storage for 30 days at −40°C), freeze–thaw stability
(three freeze at −40°C and thaw cycles) and post‐preparation stability
(storage for 12 h in the autosampler at 4°C) was tested at LQC, MQC
and HQC levels with six replicates at each level. All stability‐testing
QC samples were determined using the calibration curve of freshly
prepared standard samples.2.7 | Pharmacokinetic study
Six healthy 6–8‐week‐old Sprague–Dawley rats were purchased from
the Laboratory Animal Center of Second Military Medical University
(Shanghai, China). The animals were kept under fasting conditions
for 12 h and fed with water prior to oral administration of the ESL
at a dose of 5 g/kg. Blood samples (~400 μL) were collected from
the fosse orbital vein into heparinized polythene tubes at 0 (before
dosing), 0.17, 0.33, 0.5, 1, 1.5, 2, 3, 4, 6, 8, 10 and 24 h after dosing,
and then centrifuged immediately at 4600 g for 10min. The obtained
plasma was transferred into clean tubes and stored at −40°C until
analysis. In order to guarantee enough blood volume in rats, the rats
were given free access to water after 2 h of administration. The ani-
mal handling procedures were approved by the Institutional ethical
committee and conformed to the principles of the International Guide
for the Care and Use of Laboratory Animals. Non‐compartmental-
pharmacokinetic parameters were calculated DAS 2.0 (China State
Drug Administration).3 | RESULTS AND DISCUSSION
3.1 | Optimization of LC conditions
Chromatographic conditions were optimized to improve peak shape,
increase sensitivity and shorten run time for simultaneous analysis of
five flavonoids. At the onset of the experiments, different mobile
phase compositions were tried to achieve good resolution and
symmetric peak shapes for each analyte and the IS. The mobile phase
had been tested with acetonitrile–water and methanol–water binary
solvent system using different buffers such as ammonium formate
and formic acid. Finally, the mobile phase consisted of methanol–water
containing 0.1% formic acid with a gradient elution, which could
improve the symmetry of peak shape and enhance the signal response.TABLE 1 Tandem mass spectrometric parameters of five flavionds
and IS
Analytes
Precursor
ion
Produce
ion
Fragmentor
(V)
CE
(eV)
Stelleranol 559.2 153.0 125 24
Chamaechromone 543.3 198.9 125 4
Neochamaejasmin A 543.2 153.0 125 16
Chamaejasmine 543.1 152.9 125 16
Isochamaejasmin 543.2 153.0 125 16
Quercetin 303.1 153.1 125 353.2 | Optimization of MS conditions
In order to optimize Agilent Jet Steam (AJS) ESI determination condi-
tions, we collected the mass spectra of five flavonoids and IS under
both positive and negative ion detection mode. The results showed
that the intensity of the most abundant molecule ion for each analyte
produced in positive‐ion mode was much stronger than that in nega-
tive‐ion mode. Detection was finally operated in positive‐ion mode in
this study. Precursor ions, product ions, collision energy and the frag-
ment voltage of each analyte were optimized by Optimizer software,
which comes with the triple quad. The MS/MS transitions and energyparameters of the five compounds are shown in Table 1. Considering
that other MS parameters also play an important role in the ion
response of analytes, we performed some fine‐tuning on the basis of
autotuning. Finally, other parameters were set as follows: a sheath
gas temperature of 300°C; a sheath gas flow of 12 L/min; a nozzle
voltage of 2000 V; a nebulizer pressure of 45 psi; a capillary voltage
4000 V; a drying gas temperature of 200°C; and a drying gas flow of
5 L/min.3.3 | Optimization of sample preparation
We compared protein precipitation with LLE during sample prepara-
tion. The former was discarded because of its high noise level and
interference by endogenous substances. The latter offered a clean
sample and high response. Ethyl acetate was used as the LLE solvent
for sample preparation since these five flavonoids were extracted from
the ethyl acetate part of S. chamaejasme L.3.4 | Method validation
3.4.1 | Specificity
Typical chromatograms obtained from blank plasma, blank plasma
spiked with six analytes and plasma samples from the rats after oral
administration of ESL are shown in Figure 2. The retention times of
stelleranol, chamaechromone, neochamaejasmin A, chamaejasmine,
isochamaejasmin and IS were 2.4, 3.5, 3.9, 4.3, 5.1 and 2.9min, respec-
tively. All of the peaks of the analytes and IS were detected with excel-
lent peak resolution (R > 2.0) as well as peak shapes, and no
interference from the endogenous substances was observed at the
retention times of the analytes and IS.
3.4.2 | Linearity, LLOQ and LLOD
The equations of linear regression and linearity range for the six
analytes are shown in Table 2. The results showed good linearity
and all correlation coefficients were >0.9950. The LLOD with a sig-
nal‐to‐noise ratio >3 ranged from 0.1700 to 0.2133 ng/mL, whereas
the LLOQ with an signal‐to‐noise ratio >5 ranged from 0.5100 to
0.6400 ng/mL, which was sensitive enough for our pharmacokinetic
studies using rat plasma.
3.4.3 | Accuracy and precision
The intra‐ and inter‐day accuracy and precision data of five flavonoids
in rat plasma are listed in Table 3. At each QC and LLOQ level, the
FIGURE 2 Multiple reaction monitoring chromatograms of five flavonoids and internal standard in (a) blank plasma, (b) blank plasma spiked with
LLOQ samples, (c) plasma obtained from a rat 2 h after oral administration. 1, Stellerano; 2, quercetin (IS); 3, chamaechromone; 4, neochamaejasmin
A; 5, chamaejasmine; 6, isochamaejasmin
TABLE 2 Regression equation, LOD and LOQ of five flavonoids in rat plasma
Analytes Regression equation Linear range (ng/mL) r LOQ (ng/mL) LOD (ng/mL)
Stelleranol y = 0.0472x + 0.5680 0.6400–1280 0.9967 0.6400 0.2133
Chamaechromone y = 0.0180x + 0.0789 0.5300–1060 0.9990 0.5300 0.1767
Neochamaejasmin A y = 0.0581x + 0.2892 0.5275–1055 0.9991 0.5275 0.1758
Chamaejasmine y = 0.0182x + 0.2660 0.5800–1160 0.9956 0.5800 0.1933
Isochamaejasmin y = 0.0308x + 0.1657 0.5100–1020 0.9994 0.5100 0.1700
TABLE 3 Summary of precision, accuracy, recovery and matrix effect in rat plasma (n = 5–6)
Analytes
Concentration
(ng/mL)
Intra‐day precision,
RSD (%)
Inter‐day precision,
RSD (%)
Accuracy,
RE (%)
Absolute recovery
(%, mean ± SD)
Matrix effect
(%, mean ± SD)
Stelleranol 0.640 6.4 8.2 6.21 — —
1.280 5.6 6.1 −2.31 84.65 ± 5.91 93.21 ± 7.79
64.00 2.1 4.9 −9.44 97.32 ± 4.26 89.89 ± 6.25
640.0 2.6 4.4 5.19 83.84 ± 3.56 80.48 ± 7.15
Chamaechromone 0.530 5.2 7.2 9.21 — —
1.060 0.3 5.5 −10.21 87.41 ± 3.17 95.35 ± 7.99
53.00 3.9 4.8 −9.06 96.82 ± 7.6 83.09 ± 6.25
530.0 4.9 4.6 3.28 98.93 ± 5.63 99.83 ± 3.09
Neochamaejasmin A 0.528 4.5 10.2 1.23 — —
1.055 3.1 9.3 0.29 97.14 ± 7.47 85.34 ± 6.13
52.75 2.2 3.5 5.31 94.12 ± 3.32 97.66 ± 4.47
527.5 7.4 4.8 −7.31 81.26 ± 5.68 85.94 ± 5.80
Chamaejasmine 0.580 6.4 3.4 4.13 — —
1.160 6.3 2.3 −11.79 88.44 ± 6.44 86.73 ± 5.21
58.00 4.1 7.4 −9.02 92.74 ± 5.71 87.44 ± 5.98
580.0 4.3 2.9 2.76 93.77 ± 3.44 84.65 ± 4.72
Isochamaejasmin 0.510 4.2 2.3 4.22 — —
1.020 3.2 3.0 3.99 80.16 ± 7.00 96.82 ± 5.40
51.00 1.9 4.5 −9.39 94.15 ± 5.43 87.73 ± 3.24
510.0 6.4 4.9 −9.14 83.74 ± 6.71 85.24 ± 7.08
Quercetin (IS) 94.20 — — — 95.34 ± 8.14 90.67 ± 4.65
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0.3–10.2% and the accuracy was −11.79–9.21%. The results for both
intra‐ and inter‐day were found to be within the acceptance criteria.3.4.4 | Recovery and matrix effect
The data of recovery and matrix effect of the five flavonoids are
summarized in Table 3. Mean absolute recoveries of stelleranol,
TABLE 4 Stability data of five flavonoids in rat plasma (n = 3)
Analytes
Concentration
(ng/mL)
Accuracy (%) (mean ± SD)
Autoinjector Short‐term Freeze–thaw Long‐term
Stelleranol 1.280 97.78 ±6.06 95.05 ±8.32 83.98 ±7.68 90.27 ± 10.4
64.00 91.55 ± 9.80 91.56 ± 7.16 93.90 ± 6.96 96.85 ± 9.92
640.0 96.06 ± 4.33 95.33 ± 9.21 92.47 ± 7.95 86.01 ± 9.49
Chamaechromone 1.060 92.40 ±8.47 98.74 ± 4.80 96.81 ± 4.03 87.16 ± 7.74
53.00 90.28 ± 8.54 90.12 ± 3.31 98.18 ± 4.79 94.58 ± 9.73
530.0 96.74 ± 5.84 93.66 ± 5.88 94.20 ± 8.40 91.67 ± 6.30
Neochamaejasmin A 1.055 90.33 ± 10.33 97.44 ± 7.24 85.70 ± 6.05 91.73 ± 10.26
52.75 101.98 ± 3.25 91.31 ± 5.68 96.10 ± 8.73 85.35 ± 7.16
527.5 94.25 ± 5.90 90.93 ± 7.06 98.68 ± 4.58 87.05 ± 8.22
Chamaejasmine 1.160 92.06 ±7.99 90.71 ± 5.99 93.48 ± 7.44 89.07 ± 5.13
58.00 98.08 ± 8.17 99.50 ± 8.73 103.87 ±8.91 92.83 ± 7.64
580.0 97.91± 6.01 92.14 ± 4.42 98.36 ± 6.02 91.74 ± 9.25
Isochamaejasmin 1.020 94.53 ±7.38 95.10 ± 7.69 97.54 ± 8.21 88.70 ± 5.71
51.00 94.21 ± 6.46 92.33 ± 6.80 102.44 ± 6.40 96.50 ± 10.47
510.0 90.15 ± 10.00 93.45± 8.51 94.89 ± 3.49 89.74 ± 4.18
FIGURE 3 Mean (±SD) plasma concentration–time curves of five flavonoids in rats after oral administration of ESL (n = 6)
TABLE 5 Pharmacokinetic parameters of five flavonoids in rats after oral administration
Parameters Stelleranol Chamaechromone Neochamaejasmin A Chamaejasmine Isochamaejasmin
Cmax (μg/L) 73.47 ± 1.19 152.07 ± 3.62 104.56 ± 9.28 64.21 ± 7.92 75.73 ± 12.31
Tmax (h) 0.51 ± 0.10 0.33 ± 0.18 0.55 ± 0.12 0.33 ± 0.18 0.50 ± 0.05
t1/2 (h) 5.28 ± 0.34 5.28 ± 0.24 5.32 ± 0.91 5.42 ± 1.27 5.12 ± 1.38
AUC0–t (h μg/L) 67.32 ± 11.03 525.51 ± 14.29 99.47 ± 2.33 81.56 ± 14.32 108.97 ± 21.49
AUC0–∞ (h μg/L) 68.11 ± 9.94 544.01 ± 11.35 101.29 ± 3.84 84.84 ± 16.27 111.49 ± 19.39
AUMC0–∞(h h μg/L) 176.41 ± 10.22 4062.04 ± 23.08 351.46 ± 26.75 483.11 ± 20.90 482.37 ± 30.24
MRT0–∞ (h) 2.24 ± 1.47 7.47 ± 1.02 3.47 ± 0.99 5.70 ± 1.62 4.33 ± 2.02
Cmax, Peak concentration; Tmax, time to Cmax; t1/2, elimination half‐life time; AUC, area under the concentration–time curve; AUMC, area under the first
moment of the plasma concentration‐time curve; MRT, mean residence time.
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maejasmin were 83.84–97.32, 87.41–98.93, 81.26–97.14, 88.44–
93.77 and 80.16–94.15% at three QC levels. The results suggested
that the sample preparation and extraction methods were effective
and stabile. The matrix effects derived from QC samples were
between 80.48 and 99.83%. These results confirmed that there
were no significant matrix effects.3.4.5 | Stability
The stability data of the five flavonoids in rat plasma including room
temperature stability (storage for 6 h at ambient temperature), long‐
term stability (storage for 30 days at −40°C), freeze–thaw stability
(three freeze at −40°C and thaw cycles) and post‐preparation stability
(storage for 12 h in the autosampler at 4°C) are shown in Table 4. The
results indicate that all analytes were stable in rat plasma and
processed samples under different storage conditions.3.5 | Pharmacokinetic study
The newly developed method was sufficiently sensitive to determine
the plasma concentration of stelleranol, chamaechromone, neochama-
ejasmin A, chamaejasmine and isochamaejasmin following a single oral
administration of ESL. The concentration–time curves of the five
flavonoids are shown in Figure 3 and its estimated pharmacokinetic
parameters calculated by DAS 2.0 software are presented in Table 5.
As shown in Table 5, the range of peak concentrations (Cmax) of these
five flavonoids was from 64.21 to 152.07 μg/L because the contents
of five flavonoids varied greatly in the ESL. All five flavonoids achieved
the maximum plasma concentration within 0.55 h after oral administra-
tion, while their elimination half‐life times (t1/2) were around 5 h, which
suggests that these five flavonoids had similar elimination rates in rat
plasma after oral administration of ESL.
In a previous study, only chamaechromone has been investigated
in an in vivo analysis method (Lou et al., 2011), but its plasma concen-
tration of LLOD was not low enough, and did not satisfy the require-
ments of our study. In the literature, a double‐peak phenomenon has
been found in the plasma concentration–time curve after oral adminis-
tration of purified chamechromone, which was probably caused by
enterohepatic circulation. However, no double‐peak phenomenon
was found in our study. The time to peak concentration (Tmax) was
about 11 h and t1/2 was about 30 h, which was much later than
reported in our results. The reason for this may be that we adminis-
tered ESL orally to the rats rather than purified chamaechromone
and drug–drug interaction would influence the absorption and elimina-
tion of flavonoids, which also requires further experiments for proof.
These results should be useful for further studies on the pharmacoki-
netics, pharmaceutics and clinical practice of S. chamaejasme L.4 | CONCLUSION
An UPLC‐MS/MS method was developed and validated for the simul-
taneous determination of stelleranol, chamaechromone, neochama-
ejasmin A, chamaejasmine and isochamaejasmin in rat plasma. This is
the first paper to simultaneously determinate these five flavonoids inrat plasma after oral administration of ESL. The advantages of this
method include simple sample preparation, high sensitivity and short
run time (7.0min per sample). Moreover,this method was successfully
applied to a pharmacokinetic study of ESL in rats. The results might be
helpful for investigating the bioactivity mechanism and clinical applica-
tion of S. chamaejasme L.
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